Moreover, we identified a six-biomarker serum panel consisting of CTSL-1, SORT1, SAA4, TNFRSF10A, ST6GAL1, and CCL-18 proteins that effectively distinguished the two cohorts of RA patients from healthy donors. Here, TNFRSF10A is linked to rheumatoid arthritis.